NYSE:ROL

Bragar Eagel & Squire, P.C. Is Investigating Intuit, Rollins, Avaya, and RBC and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, August 16, 2022
U.S. Securities and Exchange Commission, AVYA, Documentation, NYSE, GLOBE, Avaya, SEC, JPMorgan Chase, Rollins, The Wall Street Journal, Security (finance), Annual report, Goldman Sachs, Review, Company, Mission statement, RBC, Audit committee, COO, TurboTax, NASDAQ, News, FTC, INTU, Affect, Online gambling, Audit, Renewable energy, P.C, Intuit

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On May 4, 2022, Intuit agreed to pay $141 million to settle similar allegations regarding Turbo Tax.
  • For more information on the RBC investigation go to: https://bespc.com/cases/ROLL
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Rollins, Inc. Investors to Inquire About Securities Class Action Investigation – ROL

Retrieved on: 
Thursday, August 11, 2022
Titan, U.S. Securities and Exchange Commission, Documentation, NYSE, TO, SEC, Facebook, Advertising, Review, Twitter, I-Space (Chinese company), WHY, News, LinkedIn, Security (finance), Online gambling

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=2735 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=2735 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Rollins Inc. Names Kenneth Krause Chief Financial Officer

Retrieved on: 
Tuesday, August 2, 2022
MSA Safety, Target, Acquisition, CFO, University, Dow Jones & Company, Insurance, KPMG, Business, Internal audit, NYSE, Climate change, Failure, Risk management, Board, COVID-19, Safety, Weather, News, Principal, MBA, Company, MSA, Board of directors, Senior, Certified Public Accountant, Western Pest Services, Management

ATLANTA, Aug. 2, 2022 /PRNewswire/ -- Rollins, Inc. (NYSE:ROL) ("Rollins" or the "Company"), a premier global consumer and commercial services company, announced today that Kenneth Krause was named Executive Vice President, Chief Financial Officer and Treasurer and Principal Financial Officer, effective September 1, 2022.

Key Points: 
  • ATLANTA, Aug. 2, 2022 /PRNewswire/ -- Rollins, Inc. (NYSE:ROL) ("Rollins" or the "Company"), a premier global consumer and commercial services company, announced today that Kenneth Krause was named Executive Vice President, Chief Financial Officer and Treasurer and Principal Financial Officer, effective September 1, 2022.
  • "We are pleased to welcome Ken Krause as our new CFO and look forward to him making a strong contribution to our leadership team," said Jerry Gahlhoff Jr., President and Chief Operating Officer at Rollins.
  • "Ken's unique combination of strategic, operational and financial expertise support his passion for helping companies deliver long-term shareholder value," Gahlhoff said.
  • Mr. Krause has been serving as Senior Vice President, Chief Financial Officer and Treasurer at MSA Safety Incorporated, a global safety equipment manufacturer with 2021 revenues of $1.4 billion since 2015.

Rollins Inc. Board of Directors Approves 2023 CEO Succession Plan

Retrieved on: 
Wednesday, July 27, 2022
Target, Acquisition, Rollins, Inc., Pleasure, CEO, NYSE, SEC, Culture, Risk, Board, Forward-looking statement, Jimmy Buffett sound board live albums, News, Leadership, Achievement, COO, Director, Company, Board of directors, Annual report, Growth, Western Pest Services, Renewable energy, Management, Risk management

ATLANTA, July 27, 2022 /PRNewswire/ -- Rollins Inc. (NYSE: ROL), a premier global consumer and commercial services company, announced today that its Board of Directors has unanimously approved the Company's long-term leadership succession plan.

Key Points: 
  • ATLANTA, July 27, 2022 /PRNewswire/ -- Rollins Inc. (NYSE: ROL), a premier global consumer and commercial services company, announced today that its Board of Directors has unanimously approved the Company's long-term leadership succession plan.
  • The plan provides that effective January 1, 2023, the Company's current President and Chief Operating Officer, Jerry Gahlhoff Jr., isexpected to become Rollins' President and Chief Executive Officer.
  • I am extremely pleased with our succession plan and our outstanding leadership team."
  • He was named President and COO of Rollins in 2020 and joined the Board of Directors in 2021.

ROLLINS, INC. ANNOUNCES REGULAR QUARTERLY CASH DIVIDEND

Retrieved on: 
Tuesday, July 26, 2022
Target, Rollins, NYSE, Board, News, Director, Company, Western Pest Services, Holding company, Agriculture

ATLANTA, July 26, 2022 /PRNewswire/ -- Rollins, Inc. (NYSE:ROL), a premier global consumer and commercial servicescompany announced that the Board of Directors declared a regular quarterly cash dividend on its common stock of $0.10 per share payable September 9, 2022 to stockholders of record at the close of business on August 10, 2022.

Key Points: 
  • ATLANTA, July 26, 2022 /PRNewswire/ -- Rollins, Inc. (NYSE:ROL), a premier global consumer and commercial servicescompany announced that the Board of Directors declared a regular quarterly cash dividend on its common stock of $0.10 per share payable September 9, 2022 to stockholders of record at the close of business on August 10, 2022.
  • Rollins, Inc. is a premier global consumer and commercial services company.
  • Through its family of leading brands, Orkin, HomeTeam Pest Defense, Clark Pest Control, Northwest Exterminating, McCall Service, Trutech, Critter Control, Western Pest Services, Waltham Services, OPC Pest Services, The Industrial Fumigant Company, PermaTreat, Crane Pest Control, Missquito, Orkin Canada, Orkin Australia, Safeguard (UK), Aardwolf Pestkare (Singapore), and more, the Company and its franchises provide essential pest control services and protection against termite damage, rodents and insects to more than 2.8 million customers in North America, South America, Europe, Asia, Africa, and Australia from more than 800 locations.
  • You can learn more about Rollins and its subsidiaries by visiting our web site at www.rollins.com , where you can also find this and other news releases by accessing the news releases button.

Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and the WWE and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 21, 2022
Hush, Death, Sale, The Wall Street Journal, United, GLOBE, Documentation, WWE, Health Insurance Portability and Accountability Act, Rollins, U.S. Securities and Exchange Commission, HIPAA, Female, CEO, NYSE, SEC, CORT, Board, Period. End of Sentence., Corcept Therapeutics, NASDAQ, Accountability Act, Civilian Complaint Review Board, News, Review, Company, P.C, Record, Annual report, District, McMahon, Online gambling, Audit, Animal, Enochian

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Enochians stock fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022.
  • Dr. Gumrukcu sold 253,493 shares of Enochian stock on May 18, 2022, for a total value of over $2 million.
  • For more information on the WWE investigation go to: https://bespc.com/cases/WWE
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and Target and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, July 16, 2022
SEC, News, U.S. Securities and Exchange Commission, Rollins, Review, GLOBE, United, Income, NYSE, Corcept Therapeutics, Record, District, Health Insurance Portability and Accountability Act, Documentation, NASDAQ, Sale, Company, HIPAA, TGT, Death, Target Corporation, Annual report, Accountability Act, Period. End of Sentence., Target, CORT, Private investigator, Online gambling, Audit, Renewable energy, Enochian, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Enochians stock fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022.
  • Dr. Gumrukcu sold 253,493 shares of Enochian stock on May 18, 2022, for a total value of over $2 million.
  • For more information on the Target investigation go to: https://bespc.com/cases/TGT
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Is Investigating Corcept, Rollins, Target, and TG Therapeutics and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, July 11, 2022
Target, TGT, FDA, Chronic lymphocytic leukemia, News, Adult, Regulation of tobacco by the U.S. Food and Drug Administration, Oncology Drug Advisory Committee, Umbralisib, Therapy, Lymphocytosis, Rollins, District, NYSE, Shanda, Documentation, Food, CLL, TG, Record, Company, SLL, Period. End of Sentence., U.S. Securities and Exchange Commission, HIPAA, ODAC, Income, Health Insurance Portability and Accountability Act, Corcept Therapeutics, Review, Sale, GLOBE, Accountability Act, Patient, SEC, Follicular lymphoma, BLA, Target Corporation, Annual report, NASDAQ, CORT, Online gambling, Audit, Renewable energy, Medical device, U2, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, TG Therapeutics' stock price fell $8.16 per share, or 34.93%, to close at $15.20 per share on November 30, 2021.
  • For more information on the TG Therapeutics investigation go to: https://bespc.com/cases/TGTX
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

ROLLINS, INC. SCHEDULES DATE FOR RELEASE OF SECOND QUARTER 2022 RESULTS

Retrieved on: 
Tuesday, July 5, 2022
Review, PIN, Internet, Company, Target, NYSE, Rollins, Western Pest Services, Rollins, Inc., News, Video game

ATLANTA, July 5, 2022 /PRNewswire/ -- Rollins, Inc. (NYSE: ROL), a premier global consumer and commercial services company, today announced that it will release its unaudited second quarter financial results for the period ended June 30, 2022 on Wednesday, July 27, 2022.

Key Points: 
  • ATLANTA, July 5, 2022 /PRNewswire/ -- Rollins, Inc. (NYSE: ROL), a premier global consumer and commercial services company, today announced that it will release its unaudited second quarter financial results for the period ended June 30, 2022 on Wednesday, July 27, 2022.
  • In conjunction with its release, the Company will host a conference call to review the Company's financial and operating results on Wednesday, July 27, 2022 at 10:00 a.m. Eastern Time.
  • Individuals wishing to participate in the conference call should call 1-877-869-3839 (domestic) or 1-201-689-8265(internationally) with conference ID of 13731028.
  • For interested individuals unable to join the call, a replay will be available until Wednesday, August 3, 2022 by dialing 1-877-660-6853 (domestic) or 1-201-612-7415 (internationally), replay PIN number 13731028.

Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and Target and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, July 5, 2022
Documentation, Review, CORT, Annual report, Death, Period. End of Sentence., TGT, Corcept Therapeutics, U.S. Securities and Exchange Commission, Target, GLOBE, Accountability Act, Sale, Company, Health Insurance Portability and Accountability Act, Record, HIPAA, United, District, NYSE, Rollins, SEC, NASDAQ, News, Income, Target Corporation, Private investigator, Online gambling, Audit, Renewable energy, Enochian, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Enochians stock fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022.
  • Dr. Gumrukcu sold 253,493 shares of Enochian stock on May 18, 2022, for a total value of over $2 million.
  • For more information on the Target investigation go to: https://bespc.com/cases/TGT
    About Bragar Eagel & Squire, P.C.